Skip to main content

Montreal, March 13th, 2024 – Alexander Magi, a seasoned veteran in philanthropic endeavours, proudly announces his collaboration with close friend Domenico D’Amato in the upcoming Visionaries of the Year 2024 campaign, dedicated to supporting the blood cancer community.

As a long-time advocate for this cause, Alexander brings his passion and commitment for the third consecutive year as a team member. His alliance with Domenico marks a significant step in their joint efforts to raise funds and awareness for the mission to combat blood cancers.

The Visionaries of the Year campaign, hosted by the Leukemia & Lymphoma Society of Canada, presents a platform for individuals like Alexander and Domenico to make a tangible impact by funding life-changing research and patient support programs across Canada. Alexander expresses his eagerness to contribute to this noble cause and make a lasting difference in the lives of those affected by blood cancers.

“Being part of this campaign for the past two years has been incredibly rewarding. Joining forces with Domenico, a dear friend who shares the same dedication, amplifies our ability to support patients and fund vital research in the fight against blood cancers.” – Alexander Magi.

With unwavering determination, Alexander pledges to raise $5,000 as a member of Domenico’s team, whose collective goal is to raise over $100,000. Alexander will channel his energy into driving support for this cause and invite others to join their journey in making a meaningful impact.

You can support Alexander in his efforts by making a donation between March 21st and May 30th, 2024 by clicking here.
The Visionaries of the Year 2024 campaign holds promise in transforming the landscape for blood cancer patients, and Alexander, alongside Domenico and their team, stands firm in their commitment to the cause.

For more information about the Visionaries of the year campaign or the Leukemia and Lymphoma Society of Canada, please visit

LLSC Contact Information:
Samantha Di Lullo

Leave a Reply